News & analysis, rated.
Breaking AI developments, in-depth guides, real-world case studies, and analysis — each one rated so you know what matters.
Cytospire raises $83M for gamma delta T cell engagers
London biotech targets solid tumors with pan-gamma delta T cell engagers, claiming better tumor infiltration than conventional CD3-targeting therapies.
FDA narrows CBER director search to 3-4 final candidates
The agency hopes to fill the key biologics oversight role that has been vacant since September, according to sources familiar with the search.
Vertex kills mRNA cystic fibrosis drug over safety issues
Major CF drugmaker drops genetic medicine program citing tolerability problems that mirror broader mRNA delivery challenges.
Cytokinetics doubles heart drug market after Bristol Myers failure
Drug company succeeds in trial for second form of heart muscle disease, expanding addressable market for hypertrophic cardiomyopathy pill.
Alzheimer's biomarker testing patterns analyzed across 234K patients
Real-world clinical data shows how doctors order and sequence Alzheimer's biomarker tests outside controlled trials, revealing practice variability.
NVIDIA packages cuOpt GPU solver as agent skills for LLM workflows
NVIDIA released cuOpt agent skills that let LLMs call GPU-accelerated optimization solvers through natural language prompts for supply chain planning.
Anthropic forms AI services company with Blackstone, H&F, Goldman
New firm will deploy Claude at mid-sized companies with Applied AI engineers from Anthropic and backing from major asset managers.
OpenAI rebuilt its WebRTC stack for real-time voice AI
The company details its infrastructure overhaul to support low-latency conversational AI with proper turn-taking mechanics.
OpenAI partners with PwC to build AI agents for finance teams
The collaboration targets CFO workflows with automated forecasting and controls, but details on capabilities remain thin.
Gemini API adds webhooks to end polling for long-running jobs
Google's new event-driven webhooks push job completion notifications to developers instead of requiring continuous polling for batch operations.
Musk admits xAI distills OpenAI models during trial testimony
Elon Musk testified that his AI company distills OpenAI's models to train its own, while suing OpenAI for allegedly breaking its nonprofit mission.
AI agents will mediate voting and civic action within two years
Personal AI assistants will soon research candidates, draft communications, and lobby on users' behalf, fundamentally changing how citizens interact with democracy.